These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33179537)

  • 1. Improving the accuracy of unbound fraction measurement of drug-protein binding by preconditioning the RED membrane inserts.
    Ye Z; Chen Q
    Bioanalysis; 2020 Dec; 12(23):1699-1708. PubMed ID: 33179537
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and validation of a higher-throughput equilibrium dialysis assay for plasma protein binding.
    van Liempd S; Morrison D; Sysmans L; Nelis P; Mortishire-Smith R
    J Lab Autom; 2011 Feb; 16(1):56-67. PubMed ID: 21609686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of recovery on fraction unbound using equilibrium dialysis.
    Di L; Umland JP; Trapa PE; Maurer TS
    J Pharm Sci; 2012 Mar; 101(3):1327-35. PubMed ID: 22161810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Confidence in the Determination of Free Fraction for Highly Bound Drugs Using Bidirectional Equilibrium Dialysis.
    Chen YC; Kenny JR; Wright M; Hop CECA; Yan Z
    J Pharm Sci; 2019 Mar; 108(3):1296-1302. PubMed ID: 30326208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mathematical and Experimental Validation of Flux Dialysis Method: An Improved Approach to Measure Unbound Fraction for Compounds with High Protein Binding and Other Challenging Properties.
    Kalvass JC; Phipps C; Jenkins GJ; Stuart P; Zhang X; Heinle L; Nijsen MJMA; Fischer V
    Drug Metab Dispos; 2018 Apr; 46(4):458-469. PubMed ID: 29437872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to measure protein binding of enzymatically unstable compounds in plasma.
    Ye Z; Gao H
    Bioanalysis; 2018 Apr; 10(7):451-459. PubMed ID: 29633861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy for Determining the Free Fraction of Labile Covalent Modulators in Plasma Using Equilibrium Dialysis.
    Leung C; Kenny JR; Hop CECA; Yan Z
    J Pharm Sci; 2020 Oct; 109(10):3181-3189. PubMed ID: 32663597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Counter Equilibrium Dialysis (CED) to Increase Confidence in the Measurement of Free Fraction for Challenging Compounds.
    Huang J; Yan Z; Cai J
    J Pharm Sci; 2023 Sep; 112(9):2561-2569. PubMed ID: 37187260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Method for Preventing Non-specific Binding in Equilibrium Dialysis Assays Using Solutol® as an Additive.
    Srivastava A; Pike A; Williamson B; Fenner K
    J Pharm Sci; 2021 Mar; 110(3):1412-1417. PubMed ID: 33248055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Protein Binding of Highly Bound Drugs Determined With Equilibrium Gel Filtration of Nonradiolabeled Compounds and LC-MS/MS Detection.
    Isbell J; Yuan D; Torrao L; Gatlik E; Hoffmann L; Wipfli P
    J Pharm Sci; 2019 Feb; 108(2):1053-1060. PubMed ID: 30336155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free fraction change with differing volume ratios in equilibrium dialysis: cases of non-linear drug-protein binding.
    Behm HL; Wagner JG
    J Pharm Pharmacol; 1981 May; 33(5):283-9. PubMed ID: 6116775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugs.
    Zamek-Gliszczynski MJ; Ruterbories KJ; Ajamie RT; Wickremsinhe ER; Pothuri L; Rao MV; Basavanakatti VN; Pinjari J; Ramanathan VK; Chaudhary AK
    J Pharm Sci; 2011 Jun; 100(6):2498-507. PubMed ID: 21213309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Fraction Unbound Between Liver Homogenate and Hepatocytes at 4°C.
    Riccardi K; Ryu S; Tess D; Li R; Luo L; Johnson N; Jordan S; Patel R; Di L
    AAPS J; 2020 Jul; 22(4):91. PubMed ID: 32671577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site.
    Imbs DC; Paludetto MN; Négrier S; Powell H; Lafont T; White-Koning M; Chatelut E; Thomas F
    Invest New Drugs; 2016 Feb; 34(1):41-8. PubMed ID: 26572909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bioanalytical challenge of determining unbound concentration and protein binding for drugs.
    Nilsson LB
    Bioanalysis; 2013 Dec; 5(24):3033-50. PubMed ID: 24320129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Estimation of Plasma Free Drug Fraction in Patients With Varying Degrees of Hepatic Impairment: A Methodological Evaluation.
    Li GF; Yu G; Li Y; Zheng Y; Zheng QS; Derendorf H
    J Pharm Sci; 2018 Jul; 107(7):1948-1956. PubMed ID: 29518400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.
    Pacifici GM; Viani A
    Clin Pharmacokinet; 1992 Dec; 23(6):449-68. PubMed ID: 1458763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pH on plasma protein binding in equilibrium dialysis.
    Kochansky CJ; McMasters DR; Lu P; Koeplinger KA; Kerr HH; Shou M; Korzekwa KR
    Mol Pharm; 2008; 5(3):438-48. PubMed ID: 18345638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.